202 related articles for article (PubMed ID: 19602601)
21. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
22. Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data.
Argentino G; Russo R; Maresca ID; Strazzullo T; Memoli A; Sodo M; Celentano L; Memoli B
Blood Purif; 2014; 38(3-4):219-23. PubMed ID: 25531054
[TBL] [Abstract][Full Text] [Related]
23. Icodextrin with small and short dwell enhances ultrafiltration in peritoneal dialysis patients with severe overhydration.
Kuriyama S; Otsuka Y; Iida R; Matsumoto K; Hosoya T
Perit Dial Int; 2006; 26(4):508-9. PubMed ID: 16881350
[No Abstract] [Full Text] [Related]
24. Understanding the variability in ultrafiltration obtained with icodextrin.
Lambie M; Stompor T; Davies S
Perit Dial Int; 2009; 29(4):407-11. PubMed ID: 19602605
[No Abstract] [Full Text] [Related]
25. Evaluation of intraperitoneal pressure and the effect of different osmotic agents on intraperitoneal pressure in children.
Rusthoven E; van der Vlugt ME; van Lingen-van Bueren LJ; van Schaijk TC; Willems HL; Monnens LA; Schröder CH
Perit Dial Int; 2005; 25(4):352-6. PubMed ID: 16022091
[TBL] [Abstract][Full Text] [Related]
26. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
Opatrná S; Opatrný K; Racek J; Sefrna F
Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
[No Abstract] [Full Text] [Related]
27. Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution.
Lin YF; Wu CC; Lin SH; Wang DP; Wang CN
Am J Health Syst Pharm; 2002 Dec; 59(23):2362, 2364. PubMed ID: 12489379
[No Abstract] [Full Text] [Related]
28. Peritoneal transport with icodextrin solution.
Heimbürger O
Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
[TBL] [Abstract][Full Text] [Related]
29. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
[No Abstract] [Full Text] [Related]
30. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
[TBL] [Abstract][Full Text] [Related]
31. Peritoneal transport after long-term exposure to Icodextrin in rats.
Frajewicki V; Kushnir D; Wajsbrot V; Kohan R; Shostak A; Gotloib L
Nephron; 2002 Sep; 92(1):174-82. PubMed ID: 12187100
[TBL] [Abstract][Full Text] [Related]
32. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
[TBL] [Abstract][Full Text] [Related]
33. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
[TBL] [Abstract][Full Text] [Related]
34. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
Feriani M
Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
[No Abstract] [Full Text] [Related]
35. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
36. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
[TBL] [Abstract][Full Text] [Related]
37. [Results of experimental and clinical investigations on icodextrin --review of studies presented in Charlotte (02/28-03/02/1999)].
Grzegorzewska AE
Pol Arch Med Wewn; 1999 May; 101(5):459-63. PubMed ID: 10740428
[No Abstract] [Full Text] [Related]
38. Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.
Pallotta KE; Elwell RJ; Nornoo AO; Manley HJ
Perit Dial Int; 2009; 29(1):52-7. PubMed ID: 19164253
[TBL] [Abstract][Full Text] [Related]
39. Icodextrin-induced acute pancreatitis in a peritoneal dialysis patient: a case report and literature review
.
Rubinstein S; Franjul R; Surana S; Fogel J
Clin Nephrol; 2016 Nov; 86 (2016)(11):283-286. PubMed ID: 27616762
[TBL] [Abstract][Full Text] [Related]
40. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
